Sanderling Ventures

Sanderling Ventures is an investment firm dedicated to building new biomedical companies. It was founded in 1979, which makes it one of the older firms with this specialism. Its approach is to work closely with entrepreneurs and stay involved after the first investment.

What Sanderling Ventures offers

• Early-stage biomedical financing — capital for new life science companies.
• Active management — hands-on involvement in the companies it backs, with a long-term commitment.
• Small molecule therapeutics — drug development based on small molecules.
• Biologics and vaccines — investment in biological medicines and vaccine work.
• Drug delivery, platform technologies and medical devices — further areas of interest.

Who it works with

Entrepreneurs starting biomedical companies. The firm's news items mention portfolio activity such as a clinical trial milestone at Glycomine and a merger between Graybug and CalciMedica.

Key facts

• Founded: 1979
• Focus: Biomedical companies at an early stage